BNP/CALL/BAXTER INTERNATIONAL/45/0.1/17.01.25 Share Price

Warrant

DE000PE892N1

Market Closed - Deutsche Boerse AG 20:50:30 15/05/2024 BST
0.066 EUR +4.76% Intraday chart for BNP/CALL/BAXTER INTERNATIONAL/45/0.1/17.01.25
Current month-74.62%
1 month-75.56%
Date Price Change
15/05/24 0.066 +4.76%
14/05/24 0.063 -10.00%
13/05/24 0.07 -9.09%
10/05/24 0.077 -8.33%
09/05/24 0.084 -2.33%

Delayed Quote Deutsche Boerse AG

Last update May 15, 2024 at 08:50 pm

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying BAXTER INTERNATIONAL INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PE892N
ISINDE000PE892N1
Date issued 16/02/2023
Strike 45 $
Maturity 17/01/2025 (247 Days)
Parity 10 : 1
Emission price 0.53
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.98
Lowest since issue 0.062
Delta0x
Omega 0.000000
Premium0x
Gearing0x
Moneyness 0.7872
Difference Strike 9.57 $
Difference Strike %+21.27%
Intrinsic value 0.000000

Company Profile

Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.
Sector
-
More about the company

Ratings for Baxter International Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Baxter International Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
35.43 USD
Average target price
46.47 USD
Spread / Average Target
+31.15%
Consensus